Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000759EBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10003545HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10021683HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10030463HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10040017HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10034647HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS10043869HBVENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TVIS44008149HTLV-1ENSG00000113327.17protein_codingGABRG2NoNo2566P18507
TCGA Plot Options
Drug Information
GeneGABRG2
DrugBank IDDB01205
Drug NameFlumazenil
Target IDBE0003592
UniProt IDP18507
Regulation Typeantagonist
PubMed IDs17974564; 11864636; 8693922
CitationsPadgett CL, Lummis SC: The F-loop of the GABA A receptor gamma2 subunit contributes to benzodiazepine modulation. J Biol Chem. 2008 Feb 1;283(5):2702-8. Epub 2007 Oct 31.@@Wingrove PB, Safo P, Wheat L, Thompson SA, Wafford KA, Whiting PJ: Mechanism of alpha-subunit selectivity of benzodiazepine pharmacology at gamma-aminobutyric acid type A receptors. Eur J Pharmacol. 2002 Feb 15;437(1-2):31-9.@@Whitwam JG, Amrein R: Pharmacology of flumazenil. Acta Anaesthesiol Scand Suppl. 1995;108:3-14.
GroupsApproved
Direct ClassificationImidazo[1,5-a][1,4]benzodiazepines
SMILESCCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1
Pathways
PharmGKBPA449659
ChEMBLCHEMBL407